INTRODUCTION
============

Inflammation, a physiological response to infection or tissue injury, plays a crucial role in many chronic diseases and various human cancers [@B001], [@B002]. Nuclear factor-κB (NF-κB) is a transcription factor with multiple genetic targets that controls various cellular functions, including immune inflammatory responses, cell adhesion, differentiation, apoptosis, stress-induced responses, survival, and progression of most chronic diseases [@B003], [@B004]. Because NF-κB activation has been shown to elicit chemo-resistance in certain tumors, it is a promising novel target for tumor therapy [@B005]-[@B007].

Nrf2 is a member of the CNC-basic leucine zipper (CNC-bZIP) family of transcription factors and coordinately regulates the constitutive and inducible expression of antioxidant and phase II detoxification enzymes such as heme oxygenase-1 (HO-1) and NAD (P)H:quinone oxidoreductase 1 (NQO1) via cis-acting ARE DNA elements [@B008], [@B009]. These cytoprotective genes can rapidly neutralize, detoxify, and remove invading xenobiotics. Accumulating evidence shows that Nrf2 is also a promising target for cancer chemoprevention [@B010], [@B011].

Recent evidence has suggested crosstalk between NF-κB and Nrf2 under oxidative stress. These two pathways are proposed to inhibit each other at their transcription level via protein-protein interactions or through secondary messenger effects. Thus, identification of factors that regulate crosstalk between NF-κB and Nrf2 has garnered recent interest [@B012]-[@B014]. As part of those studies, we recently identified a novel function of MafK, which can act as a modulator of NF-κB by inducing CBP-mediated p65 acetylation *in vitro* and *in vivo* [@B015]. Inactivation of the MafK pathway may represent an effective genetic approach against oxidative stress-induced human diseases.

Several anti-inflammatory or anti-oxidative phytochemicals suppress NF-κB signaling and activate the Nrf2-ARE pathway [@B016]-[@B018] suggesting that the suppression of NF-κB signaling and the activation of the Nrf2-ARE pathway may crosstalk with each other. In previous studies, we found that *Prunella vulgaris* var. *lilacina* possessed potent antioxidant and anti-inflammatory activities *in vitro* [@B019], [@B020]. *P. vulgaris* var. *lilacina* contains various compounds which are flavonoids, triterpenoids, phenolic acids such as campherol, rutin, rosmarinic acid (RA), caffeic acid (CA), ursolic acid (UA), oleanolic acid (OA) and tannins that provide a great assortment of biological properties [@B021].

Thus, the purpose of this study was to determine the anti-inflammatory effects of major compounds of *P. vulgaris* var. *lilacina* including their inhibitory effects on inflammatory mediators and regulatory effects on NF-κB and Nrf2 signaling. In addition, we also examined whether major compounds of *P. vulgaris* var. *lilacina* modulates MafK expression to regulate NF-κB signaling.

RESULTS
=======

Cytotoxicity of P. vulgaris var. lilacina compounds in RAW 264.7 cells
----------------------------------------------------------------------

The cytotoxicities of several compounds were measured in RAW 264.7 cells by using MTT assay. Cells were treated with 4 compounds (RA, OA, UA, and CA) at various concentrations (0, 10, 25, and 50 μM) for 1 h and then co-incubated with lipopolysaccharides (LPS; 1 μg/mL) for an additional 24 h. As shown in [Fig. 1](#F0001){ref-type="fig"}, in groups-treated with 25 and 50 μM compounds, the viability range of RAW 264.7 cells after exposure was 43% to 91%. In case of 10 μM treated group, cell viability was not significantly affected by the compounds. Therefore, these compounds were used at 10 μM in subsequent experiments.

![Effects of major compounds from *Prunella vulgaris* var. *lilacina* on cell viability of RAW 264.7 cells. RAW 264.7 cells were treated with major compounds of *P. vulgaris* var. *lilacina* at different concentrations (10, 25 and 50 μM). After treatment for 24h, Cell viability was quantified by MTT. The bars represent the means ± SEM of 3 experiments performed in triplicate. Statistical significance was determined relative to a control by the Student\'s t-test (^\*^P ＜ 0.05 compared with the 0 μM-treat group). RA, rosmarinic acid; OA, oleanolic acid; UA, ursolic acid; CA, caffeic acid.](BMB-47-524-g0001){#F0001}

Inhibition of LPS-induced nitric oxide (NO) and prostaglandin E2 (PGE2) production in RAW 264.7 cells
-----------------------------------------------------------------------------------------------------

To determine whether the compounds inhibit LPS-induced NO production, RAW 264.7 cells were pretreated with each compound for 24 h and then stimulated with LPS (1 μg/ml). After 24 h of stimulation, the cell medium was harvested and the production of NO was measured using a Griess assay. As shown in [Fig. 2](#F0002){ref-type="fig"}A, we found that LPS treatment significantly increased NO production to 26.1 μM; however, RA, OA, UA, and CA reduced NO production by 46.2%, 30.0%, 37.3%, and 27.3%, respectively. We also evaluated the effects of the compounds on PGE2 production in LPS-stimulated RAW 264.7 cells. As shown in [Fig. 2](#F0002){ref-type="fig"}B, stimulation with LPS (1 μg/ml) for 24 h in the absence of the compounds caused RAW 264.7 macrophages to produce PGE2 at a concentration of 3.4 ng/ml. However, RA, OA, UA, and CA significantly reduced the production of LPS-induced PGE2 by 21.8%, 42.8%, 28.4%, 38.1%, respectively.

![Effects of major compounds from *Prunella vulgaris* var. *lilacina* on LPS-induced NO (A) and PGE2 (B) production in RAW 264.7 cells. RAW 264.7 cells were treated with main compounds *P. vulgaris* var. *lilacina* (10 μM). After treatment, the supernatants were harvested and quantified the NO and PGE2 production using by ELISA. The bars represent the means ± SEM of 3 experiments performed in triplicate. Statistical significance was determined relative to a control by the Student\'s t-test (^\*^P ＜ 0.05 compared with the LPS group). RA, rosmarinic acid; OA, oleanolic acid; UA, ursolic acid; CA, caffeic acid.](BMB-47-524-g0002){#F0002}

Inhibition of NF-κB activity and Nrf2 and NF-κB target gene expression
----------------------------------------------------------------------

NF-κB activation is necessary for pro-inflammatory responses [@B022], [@B023]. Thus, we next examined the effects of the compounds on NF-κB activation by performing a luciferase activity assay. As shown in [Fig. 3](#F0003){ref-type="fig"}A, LPS treatment in the absence of the compounds induced NF-κB activity, while pretreatment with RA, OA, UA, and CA decreased NF-κB activity.

![Effect of major compounds from *Prunella vulgaris* var. *lilacina* on NF-κB activity (A) and Nrf2(B) and NF-κB (C)-dependent gene expression in LPS-induced RAW 264.7 cells. (A) The NF-κB-response-element-Luc reporter was transfected in RAW 264.7 cells. After 24 h, cells were treated with LPS and 10 μM of compounds. After 24 h, cells were lysed for the luciferase assay. (B and C) RAW 264.7 cells were treated with compounds 10 μM. After treatment for 24 h, RNA was isolated and reverse-transcribed for RT--PCR analyses. The bars represent the means ± SEM of 3 experiments performed in triplicate. Statistical significance was determined relative to a control by the Student\'s t-test (^\*^P ＜ 0.05 compared with the control group). RA, rosmarinic acid; OA, oleanolic acid; UA, ursolic acid; CA, caffeic acid.](BMB-47-524-g0003){#F0003}

Because Nrf2 is known to suppress inflammation and NF-κB is known to induce inflammation [@B024]-[@B027], we examined the possibility that the compounds activate and inhibit Nrf2 and NF-κB signaling, respectively. First, we examined whether the compounds induced the expression of Nrf2 target genes such as NQO1 and HO-1. The RAW 264.7 cells were treated with each of the 4 compounds. Total RNA was extracted from the treated cells and Nrf2, NQO1, and HO-1 mRNA expression was analyzed using real-time reverse-transcription polymerase chain reaction (RT-PCR). As shown in [Fig. 3](#F0003){ref-type="fig"}B, expression of these 3 genes was induced by each of the 4 compounds. Next, we determined the effect of the compounds on NF-κB target gene expression. As shown in [Fig. 3](#F0003){ref-type="fig"}C, each of the 4 compounds inhibited the expression of NF-κB target genes, including those encoding TNFα, cIAP2, and IκBα. Taken together, these results show that the 4 compounds are associated with Nrf2 activation and NF-κB suppression.

The effect of the compounds on MafK-mediated NF-κB signaling
------------------------------------------------------------

In a previous study, we showed that MafK is a novel modulator of NF-κB. Inactivation of the MafK expression would be regulating the NF-κB signaling [@B015]. Here, we investigated whether the compounds from *P. vulgaris* var. *lilacina* could modulate MafK expression. As shown in [Fig. 4](#F0004){ref-type="fig"}A, OA significantly decreased MafK expression, while the other compounds had no effect. Therefore, among major compounds of *P. vulgaris* var, *lilacina*, OA could be expecting to regulate the expression of MafK as a NF-κB inhibitor.

![Effects of major compounds from *Prunella vulgaris* var. *lilacina* on MafK expression and NFκB signaling in MafK depletion cells. (A) RAW 264.7 cells were treated with compounds (10 μM). After treatment for 24 h, whole cell lysates were subjected to western blot analysis of anti-MafK. β-actin was used as internal control. (B) RAW 264.7 cells were transfected with siMafK or control siRNA and after 24 h, cells were treated with OA (10 μM). And after another 24h, LPS (1 μg/mL) followed by measurement of IκBα degradation, phosphorylation and p65 acetylation in lysates after 5, 15, 30, and 60 min. β-actin was used as internal control. RA, rosmarinic acid; OA, oleanolic acid; UA, ursolic acid; CA, caffeic acid.](BMB-47-524-g0004){#F0004}

To determine whether the OA-mediated inhibition of MafK proteins affected NF-κB signaling, we examined IκBα phosphorylation and its subsequent degradation. As shown in [Fig. 4](#F0004){ref-type="fig"}B, OA-treated group and knockdown of MafK group did not significantly inhibit TNFα-induced IκBα degradation or phosphorylation. However, we found that OA-treated group in MafK knockdown cell inhibited IκBα phosphorylation, which was synergistically inhibited by the OA. And as previously reported, we confirmed that MafK knockdown cell were decreased the p65 acetylation. Because OA reduced the MafK expression, OA-treated group would be reducing the p65 acetylation by reduced MafK. In addition, when simultaneously OA and siMafK treat to cell, p65 acetylation did not observe. Taken together, we suggest that OA regulates NF-κB signaling via regulation of MafK expression.

DISCUSSION
==========

In our previous study, we demonstrated that *P. vulgaris* var. *lilacina* has significant anti-inflammatory effects through inhibiting the release of inflammatory mediators and cytokines, which might be due to its blocking of the NF-κB signaling pathway [@B020]. And also, we identified that a novel function of MafK, which can act as a modulator of NF-κB [@B015]. As a following study, we focused on anti-inflammatory and MafK regulating effect of major compounds of *P. vulgaris* var. *lilacina*.

The Nrf2- NF-κB pathway is a viable therapeutic target for protection against oxidative stress in various diseases. Several Nrf2 activating and NF-κB inhibiting small molecules have been identified [@B028]-[@B033]. Curcumin, a polyphenolic compound that acts via Nrf2, is suggesting that curcumin-activated Nrf2 modulates the expression and transactivation of NF-κB p65 protein levels, DNA-binding activity and promoter activity of NF-κB, increase in Nrf2 overespressing cells in the presence of curcumin [@B028]. Phenethyl isothiocyanate (PEITC) and sulforaphane attenuated LPS induced NF-κB activation via inhibit IKK/IκB phosphorylation and p65 NF-κB subunit nuclear translocation, consequently alleviating NF-κB signaling [@B029] and It activates Nrf2, possibly by modifying the sensor cysteines present in Keap1 [@B030], [@B031]. The EGCG inhibited activation of NF-κB and AP-1 thereby suppressing the COX-2 induction in mouse skin *in vivo* and/or cultured human mammary epithelial (MCF10A) cells [@B032]. EGCG also upregulated antioxidant enzymes by activating the Nrf2-ARE signaling pathway [@B033]. In the present study, we evaluated the regulatory effects of major compounds such as RA, OA, UA and CA of *P. vulgaris* var. *lilacina* on these signaling pathways and the expression of pro-inflammatory mediator, such as NO and PGE2 in LPS-stimulated RAW 264.7 macrophages. The data obtained from our current study indicated that RA, OA, UA and CA significantly inhibited LPS-induced NO and PGE2 production in RAW 264.7 cells. In addition, we found that RA, OA, UA and CA exert their inhibitory effects on these inflammatory responses via the suppression of NF-κB in the LPS-stimulated RAW 264.7 cells. Taken together, these data suggest that RA, OA, UA and CA from *P. vulgaris* var. *lilacina* contributes to anti-inflammatory effects by suppressing NF-κB activity.

The multitude of possible interactions in the Nrf2- NF-κB pathway makes the design of novel Nrf2- NF-κB pathway regulators especially difficult. Nevertheless, we identified MafK as the new regulator of Nrf2- NF-κB pathway. To find new chemicals for regulation of Nrf2- NF-κB pathway via inhibiting the MafK expression, based on the results of the present study, we evaluated the inhibition of MafK expression by RA, OA, UA and CA compounds. In the results, we confirmed a single compound "OA" with greatly inhibition than other compounds. OA significantly suppressed MafK expression and subsequently activate IκBα phosphorylation, inhibit the p65 acetylation. Taken together, these results suggest that the suppression of MafK expression by OA is mediated by the inhibition of NF-κB activation.

In conclusion, our results suggest that OA, a major compound of *P. vulgaris* var. *lilacina*, exerts potent anti-inflammatory effects by inhibiting LPS-induced NO, PGE2 in RAW 264.7 cells. These effects are mediated by inhibition of NF-κB activity via suppression of MafK expression. These findings suggest that OA as NF-κB inhibitors can potentially be used in therapeutic applications for the treatment of oxidative stress-induced diseases.

MATERIALS AND METHODS
=====================

Reagents
--------

Rosmarinic acid, oleanolic acid, ursolic acid, caffeic acid and LPS from *Escherichia coli* O55:B5 were purchased from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco's Modified Eagle's Medium (DMEM), fetal bovine serum (FBS), and penicillin- streptomycin were obtained from Invitrogen (Carlsbad, CA, USA). Antibodies against IκBα, p-IκBα, and β-actin were purchased from Cell Signaling Technology (Danvers, MA, USA). Monoclonal antibodies against MafK and Acetyl-p65 (K310) were purchased from Abcam (Cambridge, MA, USA). The NF-κB-luciferase vector was purchased from Promega (Madison, WI, USA). All other chemicals were purchased from Sigma unless otherwise specified.

Cell culture and viability
--------------------------

The RAW 264.7 macrophage cell line was purchased from the Korean Cell Line Bank (Seoul, Korea). RAW 264.7 cells were cultured in DMEM containing 10% FBS and 1% penicillin/streptomycin at 37℃ in 5% CO~2~. To investigate the cell viability of compounds cells (1 × 10^4^ cells/well) were added to duplicate 96-well plates and incubated for 24 h, then treated with various concentrations (10, 25, and 50 μM) of compounds for 24 h. Cell viability was measured using MTT assay.

NO Measurement
--------------

Nitrite was measured as an indicator of NO production after 48 h of treatment and LPS induction. The culture supernatant (100 μl) was placed in a 96-well plate, and an equal amount of Griess reagent (2% sulphanilamide and 0.2% *N*-1-(naphthyl) ethylenediamine dihydrochloride in 5% H~3~PO~4~) was added. The plate was then incubated for 10 min and the absorbance measured at 540 nm. The amount of NO was calculated using a sodium nitrite standard curve.

PGE2 Measurement
----------------

After 12 h of treatment and LPS stimulation, the culture supernatant was collected. PGE2 was measured using a PGE2 ELISA kit following the manufacturer's instructions (Abcam). Briefly, the diluted cell supernatant (100 μl) was placed in a 96-well goat anti-mouse IgG-coated plate and incubated for 2 h. After incubation, the plate was washed using the provided washing buffer, and the color was developed by adding PNPP (200 μl) substrate after 45 min. The amount of PGE2 was calculated by using a PGE2 standard curve.

Transfection of RAW 264.7 cells with pNF-κB luciferase vector
-------------------------------------------------------------

RAW 264.7 cells were transiently transfected with a pNF-κB-luciferase vector by using Lipofectamine 2000 (Invitrogen) following the manufacturer's protocol. Briefly, 5 × 10^4^ cells were placed in a 24-well plate and allowed to grow to 80-90% confluence for 24 h. The cells were then treated with DNA-Transfast reagent mixture (50 μl) and incubated for 16 h. The amount of DNA added was 0.25 μg/well. After 16 h of incubation, each well was overlaid with 1 ml of complete growth medium and the transfection was carried out for 48 h.

Real-time RT-PCR analysis
-------------------------

To determine the expression levels of Nrf2, NQO-1, HO-1, TNFα, cIAP2 and, IκBα mRNAs, real-time RT-PCR was performed using a Qiagen Rotorgene Q thermal cycler (Valencia, CA, USA) according to the manufacturer's instructions. The cells were treated with RA, OA, UA and CA and cultured for 12 h. Thereafter, cDNA was synthesized from the total RNA isolated from cells. The real-time PCR reactions were performed using 2 × SYBR Green mix (Qiagen). All results were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) expression. Primer sequences are as follows: GAPDH, 5\'-GAGCCAAAAG GGTCATCATC-3\' (forward), 5\'-TAAGCAGTTGGTGGTGCAGG-3\' (reverse); TNFα, 5\'-AGCACAGAAAGCATGATCCG-3\' (forward), 5\'-GTTTGCTACGACGTGGGCTA-3\' (reverse); cIAP2, 5\'-ATTTGA TGAAAAGCGCCAAC-3\' (forward), 5\'-AAACCAGCACGAGCAAG ACT-3\' (reverse); IκBα, 5\'-GCTGAAGAAGGAGCGGCTACT-3\'(forward), 5\'-TCGTACTCCTCGTCTTTCATGGA-3\' (reverse); Nrf2, 5\'-GAGACAGGTGAATTTCTCCCAAT-3\'(forward), 5\'-TTTGGGA ATGTGGGCAAC-3\' (reverse); NQO1, 5\'-CAGCTCACCGAGAGC CTAGT-3\' (forward), 5\'-GAGTGAGCCAGTACGATCAGTG-3\' (reverse); HO-1 5\'-GGGTGATAGAAGAGGCCAAGA-3\' (forward), 5\'-AGCTCCTGCAACTCCTCAAA-3\' (reverse).

Immunoblotting
--------------

Cells were lysed in radioimmunoprecipitation assay buffer (150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 50 mM Tris-HCl, pH 7.5, and 2 mM EDTA) on ice for 30 min. After centrifugation at 4℃ for 20 min (12,000 × g), the supernatant was collected. Protein concentrations were determined using a BCA assay (GenDEPOT; Barker, TX, USA). Equal amounts of cell extracts were separated using 12.5% SDS-PAGE and transferred to polyvinylidene difluoride membranes (Bio- Rad; Hercules, CA, USA). The membranes were blotted with antibody and detection was performed using an ECL system (Pierce; Rockford, IL USA) according to the manufacturer's instructions.

Transfection of small interfering RNA (siRNA)
---------------------------------------------

Human siRNA oligonucleotides were purchased from Integrated DNA Technologies. RAW 264.7 cells were transfected with siRNA oligos by using Lipofectamine RNAi max (Invitrogen). Twenty- four hours post-transfection, cells were treated with LPS (1 μg/ml), and were then harvested. The siRNA sense oligo sequences were as follows: control, 5\'-UUCUCCGAACGUGUCA CGUTT-3\'; siMafK, 5\'-GCCATACGCGUUUGTTCAUTT-3\'.

Statistical analysis
--------------------

Statistical analyses were performed with SPSS statistical software (version 12.0). The data represent means ± standard errors of the mean from 3 independent experiments unless otherwise stated. Statistical analyses were performed by the Student's *t*-test at a significance level of P ＜ 0.05.
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